Latest Listings And Ipos News

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.

Stavely Minerals has reported robust Phase 1 and 2 drilling results at its Fairview North and South gold prospects, revealing extensive shallow gold mineralisation with impressive high-grade intervals. A recent $1.9 million placement will fund further exploration including a Phase 3 drilling campaign and new target testing.

Mount Hope Mining has raised $2.48 million through a placement and share purchase plan to accelerate drilling at its Mt Solitary gold prospect and the broader 7.5km gold corridor in the prolific Cobar Basin.

Diatreme Resources has sold its Clermont Project subsidiaries to Moonlight Resources, receiving shares and cash, while offering its shareholders a priority IPO opportunity with free options.

Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.

Omnia Metals Group has successfully issued 54 million shares, raising $1.08 million as part of a broader $1.58 million placement. The company now looks to shareholders for approval to complete the remaining share and option issues.

HyTerra Ltd has successfully completed drilling and appraisal operations in Kansas, revealing elevated hydrogen and helium concentrations that reinforce the potential of its Nemaha Project. The company is advancing its US market presence with an OTCQB listing and strategic advisory appointments.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Lithium Plus Minerals is offering its shareholders a $3 million priority opportunity to invest in Moonlight Resources’ IPO, following Moonlight’s acquisition of the Clermont Gold Project. This move broadens Lithium Plus’s exposure beyond lithium into gold and rare earths through its 33.5% stake in Moonlight.